Mass Spectrometry & Spectroscopy
New Mass Spectrometry Portfolio: Accelerate Your Quantitative Analysis
Sep 14 2021
Accelerated workflows with enhanced sensitivity
A new TSQ Plus triple quadrupole portfolio MS portfolio from Thermo Scientific accelerates workflows through superior data acquisition and polarity switching speeds. The improved low-mass product ion transmission efficiency enhances sensitivity for key target applications. The TSQ Altis Plus, TSQ Quantis Plus and TSQ Fortis Plus MS, are suitable for a wide range of applications from targeted quantitation to cutting-edge research. Intuitive mass calibration routines and method optimisation, together with market-leading chromatography and data processing software solutions, offers improved ease of use to address future analytical challenges.
• Increased system uptime
• Simplified transfers
• Integration with mzCloud database
• Powerful quantitative application solutions
"Laboratories performing routine quantitative experiments continue to need to identify new compounds of interest across industries, such as pharma, food and environmental, resulting in rapidly changing regulations and lower detection limits," said August Specht, Vice President, Research and Development, Chromatography and Mass Spectrometry, Thermo Fisher. "In order to protect consumer and environmental health, laboratories need to provide comprehensive workflows to address evolving requirements, and the TSQ Plus triple quadrupole MS portfolio has been designed to deliver."
Professor Julijana Ivanisevic, University of Lausanne, said: "The TSQ Altis Plus platform is a step forward toward omics-scale, quantitative MS-based methodology for in-depth investigation of metabolism. The unprecedented acquisition speed of the TSQ Altis Plus allows us to maximise the metabolome coverage and significantly enhances the peak definition, essential for accurate quantification. The TSQ Altis Plus mass spectrometer allows for robust quantification of low abundant species, thus complementing the comprehensiveness of measured metabolite signature. This increase in productivity, along with the quantitative aspect, is crucial for metabolic phenotyping of human populations - a prerequisite for the transfer to clinical settings."
More information online
In This Edition Articles - The challenges of Biosample access and what needs to change - Innovative UK exports must gather income - not dust Spotlight Life Sciences - How a Pipettin...
View all digital editions
Sep 29 2021 Online event
Oct 03 2021 Prague, Czech Republic
Oct 05 2021 Paris, France
Oct 05 2021 Ricoh Arena, Coventry, UK
Oct 19 2021 Kielce, Poland